Shares of Express Scripts Holding Company (NASDAQ:ESRX) have been assigned a consensus recommendation of “Hold” from the twenty-four brokerages that are currently covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a sell recommendation, thirteen have issued a hold recommendation, five have given a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $69.57.

ESRX has been the topic of several recent analyst reports. ValuEngine cut Express Scripts Holding from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Jefferies Group LLC set a $72.00 price target on Express Scripts Holding and gave the company a “buy” rating in a report on Tuesday, August 29th. Robert W. Baird reaffirmed a “hold” rating and issued a $56.00 price target on shares of Express Scripts Holding in a report on Friday, September 1st. BidaskClub raised Express Scripts Holding from a “sell” rating to a “hold” rating in a report on Saturday, June 17th. Finally, Needham & Company LLC began coverage on Express Scripts Holding in a report on Friday, July 21st. They issued a “hold” rating on the stock.

In other news, Director Woodrow A. Myers, Jr. sold 3,900 shares of the business’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $63.93, for a total transaction of $249,327.00. Following the transaction, the director now directly owns 11,500 shares in the company, valued at approximately $735,195. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Everett Neville sold 1,163 shares of the business’s stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total transaction of $71,501.24. Following the transaction, the vice president now owns 18,232 shares in the company, valued at $1,120,903.36. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 5,641 shares of company stock worth $357,317. 0.68% of the stock is currently owned by corporate insiders.

Several institutional investors have recently bought and sold shares of ESRX. Waldron LP purchased a new position in shares of Express Scripts Holding during the 1st quarter valued at $206,000. Bowling Portfolio Management LLC purchased a new position in shares of Express Scripts Holding during the 1st quarter valued at $3,953,000. Alpha Omega Wealth Management LLC grew its holdings in shares of Express Scripts Holding by 3.0% during the 1st quarter. Alpha Omega Wealth Management LLC now owns 6,863 shares of the company’s stock valued at $452,000 after acquiring an additional 200 shares in the last quarter. Great West Life Assurance Co. Can grew its holdings in shares of Express Scripts Holding by 32.5% during the 1st quarter. Great West Life Assurance Co. Can now owns 1,059,072 shares of the company’s stock valued at $69,777,000 after acquiring an additional 259,787 shares in the last quarter. Finally, Barry Investment Advisors LLC grew its holdings in shares of Express Scripts Holding by 0.6% during the 1st quarter. Barry Investment Advisors LLC now owns 7,986 shares of the company’s stock valued at $526,000 after acquiring an additional 50 shares in the last quarter. Institutional investors and hedge funds own 88.71% of the company’s stock.

Express Scripts Holding (ESRX) traded up 0.50% during mid-day trading on Friday, reaching $62.65. The company’s stock had a trading volume of 7,853,916 shares. The stock has a market capitalization of $36.18 billion, a price-to-earnings ratio of 10.87 and a beta of 0.88. Express Scripts Holding has a 52 week low of $57.80 and a 52 week high of $77.50. The firm has a 50-day moving average of $61.89 and a 200-day moving average of $63.23.

Express Scripts Holding (NASDAQ:ESRX) last announced its earnings results on Tuesday, July 25th. The company reported $1.73 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.71 by $0.02. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The firm had revenue of $25.35 billion for the quarter, compared to analysts’ expectations of $25.52 billion. During the same quarter in the previous year, the company earned $1.57 earnings per share. The firm’s quarterly revenue was up .5% compared to the same quarter last year. On average, equities research analysts expect that Express Scripts Holding will post $6.99 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Express Scripts Holding Company (ESRX) Given Consensus Recommendation of “Hold” by Analysts” was originally published by American Banking News and is owned by of American Banking News. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.americanbankingnews.com/2017/09/17/express-scripts-holding-company-esrx-given-consensus-recommendation-of-hold-by-analysts.html.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.